Mission statement · Company scope
“Our mission is to develop innovative therapies to address areas of high unmet medical need, initially in RASopathies for NF1.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary) · Product offering · Problem–solution
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Plain
- Length
- 20 words · reading grade 15.2
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_d4bb9cf81509e8df
- Classification confidence
- 0.59
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-30 · sec_sentence · 10-K · accession 0001213900-26-036434
View filing ↗0 to compareCompare